Access the full text.
Sign up today, get DeepDyve free for 14 days.
Takashi Nakamura, Takao Yamamuro, S. Higashi, T. Kokubo, Setsuo Itoo (1985)
A new glass-ceramic for bone replacement: evaluation of its bonding to bone tissue.Journal of biomedical materials research, 19 6
T Kokubo, Y Morita, K Miyaji, N Nakanishi, N Soga, T Nakamura (1995)
Bioactivity of bioactive filler‐resin cement
M. Kobayashi, T. Nakamura, T. Kikutani, K. Kawanabe, T. Kokubo (1998)
Effect of polymerization reaction inhibitor on mechanical properties and surface reactivity of bioactive bone cement.Journal of biomedical materials research, 43 2
J. Heikkilä, Allan Aho, I. Kangasniemi, Antti Yli-Urpo (1996)
Polymethylmethacrylate composites: disturbed bone formation at the surface of bioactive glass and hydroxyapatite.Biomaterials, 17 18
T Kokubo (1993)
AW glass‐ceramic: processing and properties
M. Jasty, W. Maloney, C. Bragdon, D. O’Connor, T. Haire, W. Harris (1991)
The initiation of failure in cemented femoral components of hip arthroplasties.The Journal of bone and joint surgery. British volume, 73 4
S. Goldring, A. Schiller, M. Roelke, C. Rourke, D OʼNeil, W. Harris (1983)
The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis.The Journal of bone and joint surgery. American volume, 65 5
T. Kokubo, H. Kushitani, S. Sakka, T. Kitsugi, T. Yamamuro (1990)
Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W.Journal of biomedical materials research, 24 6
J. Charnley (1978)
Low Friction Arthroplasty of the Hip: Theory and Practice
K. Kawanabe, J. Tamura, Takao Yamamuro, Takashi Nakamura, T. Kokubo, S. Yoshihara (1993)
A new bioactive bone cement consisting of BIS-GMA resin and bioactive glass powder.Journal of applied biomaterials : an official journal of the Society for Biomaterials, 4 2
R. Kusy (1978)
Characterization of self-curing acrylic bone cements.Journal of biomedical materials research, 12 3
F. Miyaji, Y. Morita, T. Kokubo, Takashi Nakamura (1998)
Surface structural change of bioactive inorganic filler-resin composite cement in simulated body fluid: effect of resin.Journal of biomedical materials research, 42 4
L Linder, H Hansson (1983)
Ultrastructural aspects of the interface between bone and cement in man, 65B
J. Tamura, K. Kawanabe, T. Yamamuro, T. Nakamura, T. Kokubo, S. Yoshihara, T. Shibuya (1995)
Bioactive bone cement: the effect of amounts of glass powder and histologic changes with time.Journal of biomedical materials research, 29 5
N. Mohsen, Robert Craig (1995)
Effect of silanation of fillers on their dispersability by monomer systems.Journal of oral rehabilitation, 22 3
M. Freeman, G. Bradley, P. Revell (1982)
Observations upon the interface between bone and polymethylmethacrylate cement.The Journal of bone and joint surgery. British volume, 64 4
M. Kobayashi, T. Nakamura, J. Tamura, T. Kikutani, S. Nishiguchi, W. Mousa, M. Takahashi, T. Kokubo (1999)
Osteoconductivity and bone-bonding strength of high- and low-viscous bioactive bone cements.Journal of biomedical materials research, 48 3
SR Goldring, AL Schiller, M Roelke, CM Rourke, DA O'Neil, WH Harris (1983)
Formation of a synovial‐like membrane at the bone–cement interface, 65A
L. Linder, H. Hansson (1983)
Ultrastructural aspects of the interface between bone and cement in man. Report of three cases.The Journal of bone and joint surgery. British volume, 65 5
Masahiko Kobayashi, Takashi Nakamura, Y. Okada, Akira Fukumoto, T. Furukawa, H. Kato, T. Kokubo, T. Kikutani (1998)
Bioactive bone cement: comparison of apatite and wollastonite containing glass-ceramic, hydroxyapatite, and beta-tricalcium phosphate fillers on bone-bonding strength.Journal of biomedical materials research, 42 2
T. Kokubo, S. Ito, Masazumi Shigematsu, S. Sakka, T. Yamamuro (1985)
Mechanical properties of a new type of apatite-containing glass-ceramic for prosthetic applicationJournal of Materials Science, 20
A. Dupraz, J. Wijn, S. Meer, K. Groot (1996)
Characterization of silane-treated hydroxyapatite powders for use as filler in biodegradable composites.Journal of biomedical materials research, 30 2
J. Tamura, K. Kawanabe, Masahiko Kobayashi, Takashi Nakamura, T. Kokubo, S. Yoshihara, T. Shibuya (1996)
Mechanical and biological properties of two types of bioactive bone cements containing MgO-CaO-SiO2-P2O5-CaF2 glass and glass-ceramic powder.Journal of biomedical materials research, 30 1
M. Beatty, M. Swartz, B. Moore, R. Phillips, T. Roberts (1998)
Effect of microfiller fraction and silane treatment on resin composite properties.Journal of biomedical materials research, 40 1
T. Kokubo, Setsuro Ito, Z. Huang, Takeshi Hayashi, S. Sakka, T. Kitsugi, T. Yamamuro (1990)
Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W.Journal of biomedical materials research, 24 3
M. Kobayashi, T. Kikutani, T. Kokubo, T. Nakamura (1997)
Direct bone formation on alumina bead composite.Journal of biomedical materials research, 37 4
K. Hayashi, K. Uenoyama, N. Matsuguchi, S. Nakagawa, Y. Sugioka (1989)
The affinity of bone to hydroxyapatite and alumina in experimentally induced osteoporosis.The Journal of arthroplasty, 4 3
S. Haas, G. Brauer, G. Dickson (1975)
A characterization of polymethylmethacrylate bone cement.The Journal of bone and joint surgery. American volume, 57 3
Masahiko Kobayashi, Takashi Nakamura, J. Tamura, T. Kokubo, T. Kikutani (1997)
Bioactive bone cement: comparison of AW-GC filler with hydroxyapatite and beta-TCP fillers on mechanical and biological properties.Journal of biomedical materials research, 37 3
T. Kitsugi, T. Nakamura, T. Yamamura, T. Kokubu, T. Shibuya, M. Takagi (1987)
SEM-EPMA observation of three types of apatite-containing glass-ceramics implanted in bone: the variance of a Ca-P-rich layer.Journal of biomedical materials research, 21 10
J. Charnley (1979)
Low Friction Arthroplasty of the Hip
In methylmethacrylate (MMA)‐based cements containing bioactive particles, polymethylmetacrylate (PMMA) is known to suppress the bioactivity of Bioglass® and apatite‐wollastonite glass ceramic (AW‐GC). Little is known about the effect of different silane treatment methods on the bioactivity of AW‐GC. MMA‐based cement plates containing dry silanated AW‐GC particles and PMMA particles of different molecular weights (12,000–900,000) were immersed in simulated body fluid (SBF). Cements containing PMMA particles of high molecular weight formed an apatite layer on the surface after 24 h. Using PMMA particles with a molecular weight of 60,000 and AW‐GC particles silanated with different methods (dry method vs. slurry method), cement plates were made and immersed in SBF. Only cement plates containing dry silanated AW‐GC particles showed apatite formation in SBF after 3 days. In vivo implantation in rat tibias of MMA‐based cement containing dry silanated AW‐GC particles and PMMA particles (molecular weight 900,000) demonstrated an affinity index of 32.1 ± 15.8% after 8 weeks of implantation compared to 89.4 ± 10.7% achieved by bisphenol‐A‐glycidyl methacrylate based cement containing the same bioactive powder. By using a dry method of silane treatment and high molecular weight PMMA particles, the bioactivity of cement based on MMA monomer was achieved; but further effort is needed to improve the mechanical properties of the composite. © 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 47, 336–344, 1999.
Journal of Biomedical Materials Research Part A – Wiley
Published: May 5, 1999
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.